Autophagy-related molecular clusters identified as indicators for distinguishing active and latent TB infection in pediatric patients.

Autophagy-related molecular clusters identified as indicators for distinguishing active and latent TB infection in pediatric patients.

Publication date: Jun 19, 2024

Autophagy is crucial for controlling the manifestation of tuberculosis. This study intends to discover autophagy-related molecular clusters as biomarkers for discriminating between latent tuberculosis (LTBI) and active tuberculosis (ATB) in children through gene expression profile analysis. The expression of autophagy modulators was examined in pediatric patients with LTBI and ATB utilizing public datasets from the Gene Expression Omnibus (GEO) collection (GSE39939 and GSE39940). In a training dataset (GSE39939), patients with LTBI and ATB exhibited the expression of autophagy-related genes connected with their active immune responses. Two molecular clusters associated with autophagy were identified. Compared to Cluster 1, Cluster 2 was distinguished through decreased adaptive cellular immune response and enhanced inflammatory activation, according to single-sample gene set enrichment analysis (ssGSEA). Per the study of gene set variation, Cluster 2’s differentially expressed genes (DEGs) played a role in synthesizing transfer RNA, DNA repair and recombination, and primary immunodeficiency. The peak variation efficiency, root mean square error, and area under the curve (AUC) (AUC = 0. 950) were all lowered in random forest models. Finally, a seven-gene-dependent random forest profile was created utilizing the CD247, MAN1C1, FAM84B, HSZFP36, SLC16A10, DTX3, and SIRT4 genes, which performed well against the validation dataset GSE139940 (AUC = 0. 888). The nomogram calibration and decision curves performed well in identifying ATB from LTBI. In summary, according to the present investigation, autophagy and the immunopathology of TB might be correlated. Furthermore, this investigation established a compelling prediction expression profile for measuring autophagy subtype development risks, which might be employed as possible biomarkers in children to differentiate ATB from LTBI.

Open Access PDF

Concepts Keywords
Forest Active tuberculosis
Immunopathology Autophagy
Inflammatory Autophagy
Models Biomarkers
Slc16a10 Biomarkers
Child
Child, Preschool
Children
Diagnosis, Differential
Female
Gene Expression Profiling
Humans
Latent Tuberculosis
Latent tuberculosis
Male
Model
Molecular cluster
Tuberculosis

Semantics

Type Source Name
pathway KEGG Autophagy
disease MESH infection
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH latent tuberculosis
pathway KEGG Primary immunodeficiency
drug DRUGBANK Coenzyme M
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH death
disease MESH HIV infection
drug DRUGBANK BCG vaccine
pathway KEGG Apoptosis
pathway KEGG Proteasome
drug DRUGBANK Ademetionine
drug DRUGBANK Huperzine B
drug DRUGBANK L-Arginine
drug DRUGBANK Saquinavir
drug DRUGBANK Proline
disease MESH inflammation
disease MESH chronic lymphocytic leukemia
pathway KEGG Lysosome
drug DRUGBANK Esomeprazole
drug DRUGBANK Dichloroacetic Acid
disease MESH comorbidity
disease MESH pathogenesis
drug DRUGBANK Sirolimus
disease MESH starvation
disease MESH granulomas
disease MESH chronic diseases
disease MESH hepatitis
drug DRUGBANK Cholesterol
drug DRUGBANK Rifampicin
disease MESH Infectious Diseases
drug DRUGBANK Sulfasalazine
disease MESH alzheimer’s disease
pathway KEGG Peroxisome
pathway KEGG Insulin secretion
drug DRUGBANK Troleandomycin
disease MESH immune tolerance
drug DRUGBANK Dextrose unspecified form
disease MESH insulin resistance
pathway KEGG Insulin resistance

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *